Zealand Pharma and OTR Therapeutics Seal $2.5 Billion Metabolic Disease Partnership
OTR Therapeutics announced a strategic collaboration and licensing agreement with Zealand Pharma A/S (NASDAQ: ZEAL)...
Zealand Pharma
Roche and Zealand Pharma Collaborate to Develop Petrelintide for Weight Management
Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) announced a strategic exclusive collaboration and licensing...
Boehringer Ingelheim Submits Three INDs for Survodutide Phase III Trials in China
Germany-based Boehringer Ingelheim (BI) has announced the submission of three Investigational New Drug (IND) filings...